Pascale Plas

Title: Pascale Plas: Innovator in Melanocortin Receptor Research

Introduction

Pascale Plas is a notable inventor based in Chatillon, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds targeting melanocortin receptors. With a total of 8 patents to his name, his work has implications for treating various pathological disorders.

Latest Patents

Among his latest patents, Pascale Plas has developed novel pyrimido-benzimidazole derivatives that serve as agonists or antagonists of melanocortin receptors. These compounds exhibit a strong affinity for specific melanocortin receptor sub-types, especially the MC4 receptors. This innovation holds promise for treating diseases associated with these receptors. Additionally, he has created benzimidazole and imidazopyridine derivatives, which also demonstrate good affinity for melanocortin receptors. These derivatives are particularly relevant for addressing pathological states involving these receptors and include pharmaceutical compositions for drug preparation.

Career Highlights

Pascale Plas has worked with prominent companies in the pharmaceutical sector, including Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. His experience in these organizations has contributed to his expertise in drug development and receptor-targeted therapies.

Collaborations

Throughout his career, Pascale has collaborated with notable colleagues, including Lydie Francine Poitout and Carole Sackur. These partnerships have likely enriched his research and innovation efforts.

Conclusion

Pascale Plas stands out as an influential inventor in the realm of melanocortin receptor research. His innovative patents and collaborations reflect his commitment to advancing medical science and improving therapeutic options for patients.